Brian G. Drazba
2013 - Heron Therapeutics
In 2013, Brian G. Drazba earned a total compensation of $933.7K as Vice President, Finance and Chief Financial Officer at Heron Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $14,250 |
|---|---|
| Option Awards | $866,800 |
| Salary | $52,615 |
| Total | $933,665 |
Drazba received $866.8K in option awards, accounting for 93% of the total pay in 2013.
Drazba also received $14.3K in non-equity incentive plan and $52.6K in salary.
Rankings
In 2013, Brian G. Drazba's compensation ranked 6,938th out of 12,286 executives tracked by ExecPay. In other words, Drazba earned more than 43.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,938 out of 12,286 | 44th |
Division Manufacturing | 2,459 out of 4,612 | 47th |
Major group Chemicals And Allied Products | 746 out of 1,466 | 49th |
Industry group Drugs | 552 out of 1,160 | 52nd |
Industry Pharmaceutical Preparations | 437 out of 890 | 51st |
Source: SEC filing on April 29, 2016.
Drazba's colleagues
We found three more compensation records of executives who worked with Brian G. Drazba at Heron Therapeutics in 2013.